Last checked at 29 Jun 2023 18:24
FOR RELEASE ON | 29 June 2023 |
IP Group plc -Additional DBSP awards; PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.
Deferred Bonus Share Plan ("DBSP") Awards
On 14 April 2023, the Company granted a number of nil-cost options over ordinary shares of two pence each ("Shares") to certain employees under the Group's DBSP, such awards being announced to the market via RNS on 18 April 2023 (the "April 2023 DBSP Awards").
It was subsequently noted that there had been an administrative error in calculating a small number of the April 2023 DBSP Awards. As such, on 28 June 2023 the Company granted additional nil-cost options over Shares to a person discharging managerial responsibilities ("PDMR") and certain current and former employees under the Group's DBSP (the "Additional Grant"). The Additional Grant has been made on the same basis as the April 2023 DBSP Awards were made. The following table sets out details of the awards made to a PDMR:
Name of Director/PDMR | Structure of award | Number of options granted under the April 2023 DBSP | Number of options granted under the Additional Grant | Total number of options currently held |
Mark Reilly | Nil-Cost Option | 75,376 | 4,636 | 127,380 |
Total |
In addition to the above, under the Additional Grant, awards over a total of 24,202 Shares were made to certain other of the Group's employees and former employees. As at the date of this announcement, a total of 2,168,457 nil-cost options over Shares remain outstanding under the IP Group DBSP.
No consideration was paid for the grant of the awards and no consideration is due on the maturity of the option period. Fifty per cent of the options will normally be automatically exercised on 31 March 2024 and fifty per cent on 31 March 2025, with each such automatic exercise generally subject to continued employment.
Shares in issue
At the date of this announcement, the Company continues to have 1,063,188,005 Shares in issue of which 26,273,218 Shares are held in treasury.
The following information is being disclosed pursuant to the requirements of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
DBSP Awards
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | Mark Reilly | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PDMR Managing Partner, Technology | ||||||
b) | Initial notification /Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | IP Group plc | ||||||
b) | Legal Entity Identifier | 213800HG22UM138WFG43 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 | ||||||
b) | Nature of the transaction | Grant of nil-cost options under the IP Group plc DBSP | ||||||
c) | Currency | GBP | ||||||
d) | Price(s) and volume(s) |
| ||||||
e) | Aggregated information -Aggregated volume - Price - Aggregated total |
Aggregated number of options granted under the DBSP to Directors and PDMRs on 28 June 2023: 4,636 Price: £ nil | ||||||
f) | Date of the transaction | 28 June 2023 | ||||||
g) | Place of the transaction | Outside a trading venue
| ||||||
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
Liz Vaughan-Adams, Communications
Portland
Vic Wallin Alex Donaldson | +44 (0) 20 7444 0062/+44 (0) 7979 853802
+44 (0) 7973 823119 +44 (0) 7516 729702
|
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS